New Search

If you are not happy with the results below please do another search

1122 search results for:

42

OGT expands NGS operations to state-of-the-art facility in Oxford Technology Park Investment in new premises to create increase in cutting-edge genomic solutions and collaborative partnerships

OGT, a leading global provider of genomic research and diagnostic solutions, proudly announces the opening of state-of-the-art facilities within the Oxford Technology Park. The move represents a multi-million-pound investment, fuelled by consistent company growth and growing customer demand. 

44

Anti-TBEV ELISAs for CSF and serum

EUROIMMUN has introduced CE-IVDR-compliant ELISAs for detection of IgG antibodies against tick-borne encephalitis virus (TBEV) in cerebrospinal fluid (CSF) and serum samples. TBEV causes the severe and potentially fatal neurological disease TBE, which is endemic in parts of Europe and Asia and is growing in range and incidence. In TBE cases with CNS involvement, detection […]